Venture Capital

French aerospace giant Dassault Aviation partners with Harmattan AI, aiming to lead Europe's charge in the global race for sovereign, AI-driven warfare.

The new APEX platform aims to transform OEM-supplier dynamics by offering deep integration for the next wave of AI and robotic product development.

The addition of Google and NVIDIA to Si2's OpenAccess board signals a major industry shift toward collaborative, open standards for semiconductor innovation.

Hong Kong's 3E Network completes a $2M financing round, fueling its strategic shift into the competitive global AI infrastructure market.

With a $30M Series A boost, Ventaris Surgical is developing a new system to solve a persistent problem in urology: incomplete kidney stone removal.

LMU's College of Business Administration celebrates 100 years with partner Office Beacon, blending a legacy of ethical leadership with a focus on innovation.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

Meta's historic nuclear energy purchase signals a major shift in Big Tech's strategy to meet soaring AI power demands and reshape the US energy grid.

Office leasing rose 5% in 2025, but a closer look reveals a fractured recovery, with tech hubs booming while others lag and companies shrink their footprints.

With new funding, Major Medical Devices is advancing a novel AAA repair device that uses arm access, promising safer procedures and wider patient eligibility.

With a new $1.6B valuation led by T. Rowe Price, Hadrian is scaling its AI-powered factories to spearhead America's industrial and defense resurgence.

After a year of scrutiny, a former Urban League leader invests in the aspiring minority-controlled stock exchange, validating its mission for structural change.

With promising data in hard-to-treat cancers, iOnctura's lead drug, roginolisib, is set to make waves at the top healthcare investment forum.

EpicQuest Education's CES award highlights its AI university plans, but a closer look reveals a complex picture of innovation, market hype, and financial risk.

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

With a massive $200M Series A and a promising Phase 2 drug, new biotech AirNexis aims to reshape the multi-billion dollar COPD treatment landscape.

With a major investment from Santé Ventures, Brado AI is deploying conversational AI to guide patients and ease provider burdens. Here’s what it means.

With 11 straight quarters of growth and a focus on 'Physical AI,' lidar leader Ouster is set to detail its ambitious strategy for institutional investors.

After a major business sale, Elutia is launching NXT-41x, an antibiotic biomatrix designed to combat the high rate of infection in breast reconstruction.